MID PRICE
98.41
par = 100
YIELD TO MAT.
4.63%
semi-annual
COUPON
4.125%
semi-annual · fixed
MATURITY
2031-03-15
bullet · 4.85y
OUTSTANDING
—
not disclosed
AS OF
2026-05-05
Sign up free to see prices on this bond
Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.
About this bond
AI BRIEF · GROUNDED IN STRUCTURED DATAAbout the issuer
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
Source: Wikipedia →Risk analytics
SEMI-ANNUAL · BULLET · PAR 100Modified duration
4.32 y
1bp ↑ ≈ -0.043% P&L
Convexity
21.91
higher = more curvature
Years to maturity
4.85 y
YTM source
Ingested
Market signals · funds disclosing this bond
Subscribe to reveal which signals are holding this bond.Subscribe →
Price history
Sherpa Signal
AS OF 2026-05-05Institutional footprint · signal-level holdings
Interpretation. Minimal institutional footprint, with net distribution
HOLDERS
1
unchanged in 7d
AGGREGATE EXPOSURE
$5.8M
USD across all
TOP CONCENTRATION
100.0%
largest holder
FLOW
▼ $72K
unchanged in 7d
Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.
100K PAR NOTIONAL · MARKET VALUE
98,406 USD
PRICE
98.41
RFQ routing · coming soon
Security details
AWAITING ENRICHMENTFace value
100 USD
Seniority
Senior Unsecured
Issuer curve
Abbvie · 10 PTSYield (%) plotted against years-to-maturity. This bond highlighted in amber.
Bonds like this
HEURISTICSame currency & sector, maturity within 7 years. Ranked by overlapping institutional owners, issuer match, and rating distance.